Stocks and Investing
by (remove) : Kevin Fischbeck
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Kevin Fischbeck
RSSJSONXMLCSV
Mon, October 7, 2024
Wed, October 2, 2024
Mon, August 12, 2024
Wed, May 15, 2024
Thu, May 2, 2024
Thu, March 7, 2024
Wed, November 8, 2023
Thu, November 2, 2023
Fri, August 4, 2023
Thu, July 27, 2023
Fri, July 14, 2023
Fri, June 2, 2023
Thu, May 11, 2023
Mon, April 17, 2023
Tue, March 7, 2023
Fri, March 3, 2023
Tue, February 28, 2023
Fri, December 16, 2022
Tue, December 13, 2022
Thu, August 18, 2022
Fri, July 1, 2022
Thu, May 26, 2022
Wed, May 11, 2022
Wed, April 13, 2022
Tue, January 18, 2022
Tue, October 26, 2021
Fri, October 15, 2021
Tue, July 27, 2021
Tue, June 1, 2021
Mon, May 10, 2021

Kevin Fischbeck Downgraded (AMN) to Sell and Decreased Target to $48 on, Oct 7th, 2024


Published on 2024-10-28 14:41:21 - WOPRAI, Kevin Fischbeck
  Print publication without navigation


Kevin Fischbeck of B of A Securities, Downgraded "AMN Healthcare Services, Inc." (AMN) to Sell and Decreased Target from $65 to $48 on, Oct 7th, 2024.

Kevin has made no other calls on AMN in the last 4 months.



There are 4 other peers that have a rating on AMN. Out of the 4 peers that are also analyzing AMN, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Bill Sutherland of "Benchmark" Reiterated at Hold on, Wednesday, October 2nd, 2024
  • A.J. Rice of "UBS" Maintained at Hold with Decreased Target to $65 on, Friday, August 9th, 2024


These are the ratings of the 2 analyists that currently disagree with Kevin


  • Constantine Davides of "JMP Securities" Reiterated at Buy and Held Target at $66 on, Friday, October 4th, 2024
  • Jeffrey Silber of "BMO Capital" Maintained at Buy with Increased Target to $71 on, Monday, August 12th, 2024
Contributing Sources